July 16, 2009 - Principal investigator, radiologist Dr. Alexander Poellinger, and his team of researchers at the Charité, Medical University in Berlin, Germany, will use fluorescent dye to demonstrate an enhancement of the sensitivity and the specificity of diffuse optical tomography in a new a breast cancer imaging study. Imaging Diagnostic Systems Inc., a laser breast imaging systems company, launched the breast cancer imaging study to examine the potential role of its model 1020 CTLM laser breast imaging system as an enhanced breast cancer-screening tool when used in combination with the fluorescent dye, Indocyanine Green (ICG). “In other studies, optical imaging using fluorescent dyes have shown great promise to detect and differentiate malignancies. By using a fluorescent dye in a clinical breast cancer study, we hope to demonstrate an enhancement of the sensitivity and the specificity of diffuse optical tomography. For this purpose we will use a modified CTLM breast scanner that is capable of acquiring both absorption and fluorescence images," said Dr. Alexander Poellinger. The ICG fluorescent dye has a distribution pattern in the human body similar to that of extracellular MRI and CT contrast agents and it is already approved for other medical applications. The IDSI model 1020 CTLM scanner that will be used in the study has been specially modified to be able to both excite the ICG dye and image its fluorescence in breast tissue. Following injection of ICG into the patient, the scanner produces 3D images of the localized concentration of the dye. These images are expected to show increased extravazation and accumulation of the dye in malignant tissue. IDSI users have performed over 15,000 CT Laser Mammography (CTLM) clinical cases worldwide. For more information: www.imds.com
If you enjoy this content, please share it with a colleague
Related Content
July 8, 2025 — QT Imaging Holdings, has appointed Elaine Iuanow, MD, as chief medical officer (CMO) and Kim Du as senior ...
July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...
June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...
April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...
April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...
March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...
Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...
Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...
Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...
Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...